Brussels, 17 February 2026

IBBIS was proud to participate in a European Commission workshop on the biosecurity provisions of the proposed European Biotech Act.

IBBIS shared perspectives on standards and regulatory requirements for screening synthetic DNA orders, drawing on insights from the Global DNA Synthesis Map to highlight current practices, gaps, and opportunities across the EU. This contribution supported the broader dialogue on strengthening biosecurity while enabling responsible innovation. We appreciate the opportunity to contribute to this important conversation.

The workshop outcomes will inform the broader impact assessment of the proposed Biotech Act, helping to shape a secure and resilient future for synthetic biology in the EU.

You can find below the information presented by IBBIS.